Related Experiment Video
Updated: Apr 29, 2026
08:27
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
5.7K
Neurophysiology in Huntington's disease: an update
Isabella Maria Sophie Mayer1, Michael Orth
1Department of Neurology, Ulm University, Ulm, Germany.
Neurodegenerative Disease Management
|May 17, 2014
Summary
Huntington's disease (HD) biomarkers are sought. Evoked potentials show promise for diagnosing this genetic movement disorder, but require further study with neuroimaging.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by motor, cognitive, and behavioral symptoms.
- The genetic mutation in the HTT gene causes HD, but factors influencing disease onset and progression remain unclear.
- Current electrophysiological methods like transcranial magnetic stimulation and electroencephalography have not identified reliable HD biomarkers.
Purpose of the Study:
- To investigate the potential of evoked potentials as reliable biomarkers for Huntington's disease.
- To explore the relationship between electrophysiological findings and neuroimaging data in HD patients.
Main Methods:
- Review of existing electrophysiological techniques and their application in HD research.
- Focus on somatosensory evoked potentials and visual evoked potentials, noting their reduced amplitudes in manifest HD.
- Proposal for large-scale studies combining electrophysiology and neuroimaging in homogeneous patient cohorts.
Main Results:
- Evoked potentials, particularly somatosensory and visual, show consistently reduced amplitudes in manifest Huntington's disease.
- Electrophysiological techniques have advanced understanding of HD pathophysiology but lack specific biomarkers.
- No consistent abnormalities from current electrophysiological methods are suitable for reliable biomarker use.
Conclusions:
- Evoked potentials represent the most promising electrophysiological candidates for HD biomarker development.
- Further research involving large, homogeneous patient cohorts is necessary.
- Integrating electrophysiology with neuroimaging is crucial to understand neural network function and brain changes in HD.
More Related Videos
Related Concept Videos
01:21Huntington Disease l: Introduction
98
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
98
01:24Parkinson Disease ll: Pathophysiology
26
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26
01:37Neural Regulation
34.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.7K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:23Alzheimer Disease ll: Pathophysiology
34
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
34
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28